Maryland State Retirement & Pension System’s Vir Biotechnology VIR Stock Holding History

Maryland State Retirement & Pension System’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$180K	Buy	17,687 +1,524	+9%	+$14.5K	﹤0.01%	1391
2026 Q1	$145K	Buy	16,163 +2,668	+20%	+$21.3K	﹤0.01%	1324
2025 Q4	$81.4K	Hold	13,495	–	–	﹤0.01%	1359
2025 Q3	$77.1K	Sell	13,495 -14,205	-51%	-$72.6K	﹤0.01%	1363
2025 Q2	$140K	Hold	27,700	–	–	﹤0.01%	1473
2025 Q1	$179K	Sell	27,700 -3,323	-11%	-$29.5K	﹤0.01%	1416
2024 Q4	$228K	Hold	31,023	–	–	﹤0.01%	1454
2024 Q3	$232K	Hold	31,023	–	–	﹤0.01%	1463
2024 Q2	$276K	Hold	31,023	–	–	0.01%	1413
2024 Q1	$260K	Sell	31,023 -624	-2%	-$6.36K	0.01%	1420
2023 Q4	$318K	Hold	31,647	–	–	0.01%	1377
2023 Q3	$297K	Buy	31,647 +1,894	+6%	+$27K	0.01%	1361
2023 Q2	$730K	Sell	29,753 -803	-3%	-$20.2K	0.02%	826
2023 Q1	$711K	Sell	30,556 -701	-2%	-$17.9K	0.02%	808
2022 Q4	$791K	Buy	+31,257	New	+$766K	0.02%	682
2022 Q3	–	Sell	-29,976	Closed	-$763K	–	1332
2022 Q2	$763K	Buy	+29,976	New	+$700K	0.02%	662

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Maryland State Retirement & Pension System's VIR Position: Q2 2026 in Review

Maryland State Retirement & Pension System increased its Vir Biotechnology (VIR) stake by 9.4% in Q2 2026, buying an estimated $14.5K and bringing the position to 17,687 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #1391.

Maryland State Retirement & Pension System first reported a position in VIR in Q2 2022 and has held it in 16 quarters since. The position peaked at $791K in Q4 2022. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Maryland State Retirement & Pension System held 17,687 shares of Vir Biotechnology worth $180K as of Q2 2026.
Maryland State Retirement & Pension System bought 1,524 Vir Biotechnology shares in Q2 2026, an estimated $14.5K.
Vir Biotechnology made up ﹤0.01% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #1391 holding.
Maryland State Retirement & Pension System first reported a position in Vir Biotechnology in Q2 2022 and has held it in 16 quarters since.
Maryland State Retirement & Pension System's Vir Biotechnology position peaked at $791K in Q4 2022.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.